|
|
- 2019
New Technologies To Enhance In Vivo Reprogramming for Regenerative MedicineDOI: https://doi.org/10.1016/j.tibtech.2018.11.003 Abstract: CRISPR/Cas9 gene-editing systems have been reengineered as programmable transcription factors that can target nearly any gene sequence. A single effector can modulate the expression levels of multiple genes and include epigenetic modifiers
|
